December 2012

Launch of JANUMET® – combination sitagliptin and metformin hydrochloride

New Product: MSD has launched JANUMET® which is an addition to the recent introduction of JANUVIA®. The two fall into the same portfolio of new oral antidiabetic agent for the treatment of type 2 diabetes. JANUVIA® contains sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor (incretin enhancer) that increases the levels of two incretin hormones, glucagon-like

Launch of JANUMET® – combination sitagliptin and metformin hydrochloride Read More »